Miller, J., Hatoum, F., Dyer, B., Heiligh, J., Poehlman, T., Zhang, J., Jameel, G. S., Mizelle, S. R., Patel, A., Schneider, A., Fazili, A. N., Johnson, J. S., Gullapalli, K., Tannir, N. M., Msaouel, P., Campbell, M. T., Hahn, A. W., Spiess, P. E., Anderson, A. A., Chahoud, J. (2026). A multicenter, open-label, phase II study of adaptive combination immunotherapy with VEGFR-TKI for advanced renal cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps575